Navigate Ongoing COVID-19 Vaccine Changes
You’ll need to stay on top of changing COVID-19 vaccine guidance...now that monovalent mRNA products are no longer authorized.
Only about 17% of people in the US have had a bivalent dose.
But adults who’ve had a bivalent vaccine continue to have a lower risk of urgent care visits and hospitalizations than those who haven’t...even with circulating variants.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote